Penumbra, Inc. (PEN) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $325.86 (-0.19%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 26, 2026 | Priya Sachdeva | UBS | $374.00 | +14.8% |
| Jan 16, 2026 | David Rescott | Robert W. Baird | $374.00 | +14.8% |
| Jan 16, 2026 | Mike Kratky | Leerink Partners | $374.00 | +14.8% |
| Jan 16, 2026 | Richard Newitter | Truist Financial | $374.00 | +14.8% |
| Jan 15, 2026 | Ryan Zimmerman | BTIG | $349.00 | +7.1% |
| Jan 15, 2026 | Matt O'Brien | Piper Sandler | $374.00 | +14.8% |
| Jan 5, 2026 | Vijay Kumar | Evercore ISI | $340.00 | +4.3% |
| Dec 17, 2025 | Shagun Singh | RBC Capital | $355.00 | +8.9% |
| Dec 17, 2025 | Mike Matson | Needham | $388.00 | +19.1% |
| Nov 6, 2025 | William Plovanic | Canaccord Genuity | $355.00 | +8.9% |
| Oct 15, 2025 | Richard Newitter | Truist Financial | $300.00 | -7.9% |
| Apr 24, 2025 | David Rescott | Robert W. Baird | $325.00 | -0.3% |
| Apr 24, 2025 | Mathew Blackman | Stifel Nicolaus | $318.00 | -2.4% |
| Apr 15, 2025 | Shagun Singh | RBC Capital | $315.00 | -3.3% |
| Dec 11, 2024 | Larry Biegelsen | Wells Fargo | $275.00 | -15.6% |
| Oct 31, 2024 | Matt O'Brien | Piper Sandler | $235.00 | -27.9% |
| Oct 31, 2024 | Pito Chickering | Deutsche Bank | $241.00 | -26.0% |
| Oct 18, 2024 | Matt O'Brien | Piper Sandler | $225.00 | -31.0% |
| Oct 16, 2024 | Jason Mills | Canaccord Genuity | $235.00 | -27.9% |
| Oct 15, 2024 | David Rescott | Robert W. Baird | $244.00 | -25.1% |
Top Analysts Covering PEN
PEN vs Sector & Market
| Metric | PEN | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.60 | 2.24 | 2.41 |
| Analyst Count | 20 | 8 | 18 |
| Target Upside | +14.1% | +1150.3% | +14.9% |
| P/E Ratio | 72.09 | 6.80 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.55B | $1.59B | $1.63B | 10 |
| 2027-03-31 | $413M | $421M | $429M | 4 |
| 2027-06-30 | $437M | $445M | $454M | 6 |
| 2027-09-30 | $447M | $456M | $465M | 4 |
| 2027-12-31 | $470M | $479M | $489M | 7 |
| 2028-03-31 | $467M | $476M | $486M | 3 |
| 2028-06-30 | $502M | $511M | $521M | 5 |
| 2028-09-30 | $515M | $526M | $536M | 3 |
| 2028-12-31 | $521M | $531M | $541M | 6 |
| 2029-12-31 | $2.18B | $2.24B | $2.29B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $4.84 | $4.97 | $5.04 | 8 |
| 2027-03-31 | $1.40 | $1.43 | $1.47 | 3 |
| 2027-06-30 | $1.50 | $1.54 | $1.58 | 5 |
| 2027-09-30 | $1.57 | $1.61 | $1.65 | 3 |
| 2027-12-31 | $1.76 | $1.80 | $1.85 | 6 |
| 2028-03-31 | $1.46 | $1.50 | $1.54 | 4 |
| 2028-06-30 | $1.78 | $1.82 | $1.87 | 6 |
| 2028-09-30 | $1.90 | $1.95 | $2.00 | 4 |
| 2028-12-31 | $1.93 | $1.98 | $2.03 | 7 |
| 2029-12-31 | $8.12 | $8.42 | $8.68 | 2 |
Frequently Asked Questions
What is the analyst consensus for PEN?
The consensus among 20 analysts covering Penumbra, Inc. (PEN) is Hold with an average price target of $371.92.
What is the highest price target for PEN?
The highest price target for PEN is $388.00, set by Mike Matson at Needham on 2025-12-17.
What is the lowest price target for PEN?
The lowest price target for PEN is $150.00, set by Larry Biegelsen at Wells Fargo on 2024-07-31.
How many analysts cover PEN?
20 analysts have issued ratings for Penumbra, Inc. in the past 12 months.
Is PEN a buy or sell right now?
Based on 20 analyst ratings, PEN has a consensus rating of Hold (2.60/5) with a +14.1% upside to the consensus target of $371.92.
What are the earnings estimates for PEN?
Analysts estimate PEN will report EPS of $4.97 for the period ending 2026-12-31, with revenue estimated at $1.59B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.